Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome

Indian Journal of Anaesthesia

Volumn 57, Issue 1, 2013, Pages 46-51

  Ledowski, Thomas ^a,b   Hillyard, Samuel ^a   O'Dea, Brendan ^b   Archer, Rob ^b   Vilas, Filipe Boas ^b   Kyle, Barney ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Neostigmine; Residual paralysis; Sugammadex

Indexed keywords

ATRACURIUM BESILATE; DESFLURANE; MIVACURIUM; NEOSTIGMINE; OPIATE; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX; SUXAMETHONIUM; VECURONIUM;

ADULT; ARTICLE; ATELECTASIS; COMPARATIVE STUDY; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; OXYGEN DESATURATION; PARALYSIS; PNEUMONIA; PROSPECTIVE STUDY; RESIDUAL PARALYSIS; RESPIRATORY TRACT DISEASE; THORAX RADIOGRAPHY;

EID: 84875169978     PISSN: 00195049     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5049.108562     Document Type: Article

References (14)

1. Murphy GS, Brull SJ. Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence and adverse physiologic effects of residual neuromuscular block. Anaesth Analg 2010;111:120-8.
2. Baillard C, Clec'h C, Catineau J, Salhi F, Gehan G, Cupa M, et al. Postoperative residual neuromuscular block: A survey of management. Br J Anaesth 2005;95:622-6.
3. Murphy GS, Szokol JW, Franklin M, Marymont JH, Avram MJ, Vender JS. Post Anaesthesia care unit recovery times and neuromuscular blocking drugs: A prospective study of orthopedical surgical patients randomized to receive pancuronium or rocuronium. Anaesth Analg 2004;98:193-200.
4. Pühringer FK, Gordon M, Demeyer I, Sparr HJ, Ingimarsson J, Klarin B, et al. Sugammadex rapidly reverses moderate rocuronium-. or vecuronium induced neuromuscular block during sevoflurane anaesthesia: A dose-response relationship. Br J Anaesth 2010;105:610-9.
5. Beecher HK, Todd DP. A study of the deaths associated with Anaesthesia and surgery: Based on a study of 599, 548 Anaesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954;140:2-35.
6. Ali HH, Utting JE, Gray C. Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth 1970;42:967-78.
7. Kopman AF. Residual neuromuscular block and adverse respiratory events. Anaesth Analg 2008;107:1756.
8. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: A prospective, randomized and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997;41:1095-103.
9. Brull SJ, Silverman DG. Visual and tactile assessment of neuromuscular fade. Anaesth Analg 1993;77:352-5.
10. Drenck NE, Ueda N, Olsen NV, Engbaek J, Jensen E, Skovgaard LT, et al. Manual evaluation of residual curarization using double-burst stimulation: A comparison with train of four. Anaesthesiology 1998;70:578-81.
11. Brull SJ, Murphy GS. Residual neuromuscular block: Lessons unlearned. Part 2: Methods to reduce the risk of residual weakness. Anaesth Analg 2010;111:129-40.
12. Kim KS, Cheong MA, Lee HJ, Lee JM. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anaesthesia. Anaesth Analg 2004;99:1080-5.
13. Watts RW, London JA, Van Wijk RM, Lui YL. The influence of unrestricted use of sugammadex on clinical anaesthetic practice in a tertiary teaching hospital. Anaesth Intensive Care 2012;40:333-9.
14. Ledowski T, Hillyard S, Kozman A, Johnston F, Gillies E, Greeaway M, et al. Unrestricted access to sugammadex: Impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs. Anaesth Intensive Care 2012;40:340-3.